The landscape of dementia prognosis has evolved dramatically with the advent of complex biomarkers, including amyloid PET scans, tau imaging, and blood-primarily based assessments which can detect Alzheimer's pathology years prior to indicators arise. When these technological innovations represent outstanding progress in knowing neurodegenerative c